A growing number of clinicians rely on AdaptDx to detect age-related macular degeneration in their adult patients. Our customers tell the story of how they’re fighting against blindness caused by AMD.
Having had the AdaptDx in my practice for almost 5 years has reinforced my confidence level in diagnosing AMD early with 90% sensitivity and specificity. My patients appreciate this technology and early diagnosis so that we can better monitor their progress and guide them with preventive measures. My patients recognize our practice as an AMD Center of Excellence with a commitment to preventing blindness through early diagnosis and management. MacuLogix has given our doctors the tool to be leaders in early AMD diagnosis.
Having been a Vision Source Administrator for nearly 15 years, I know the mindset of the prototypical Vision Source doctor, and it is this: seek out and deliver the highest outcome patient care using the most up-to-date technology that is based on the latest peer-reviewed research. While accomplishing this worthy goal, the Vision Source doctor also watches to be certain that this increased level of care will simultaneously enhance the practice’s business well-being and also save money for the overall health care system with early diagnosis and treatment. Having also been trained extensively on dark adaptometry technology, I can wholeheartedly say that the AdaptDx instrument checks every single box for the Vision Source practitioner to accomplish all of these patient goals in the early detection and treatment of subclinical AMD.
The AdaptDx gives us the best gift of all: time to take appropriate action to slow the progression of the disease. All in all this instrument is crucial in the early detection & disease management of AMD.
Just like the OCT, I don't know how I practiced without the AdaptDx. From being able to diagnose AMD before we see any clinical signs and being able to monitor at the correct follow-up time for my patients that have AMD is wonderful. I felt like it was just a shot in the dark as to when I should have early AMD patients return, but now knowing their rod intercept, I can confidently say exactly when their follow-ups should be.
When I purchased my OCT, I must admit there was a learning curve reading the scans. With the AdaptDx, there is only the Rod Intercept to evaluate, so it was extremely easy to interpret and therefore incorporate into my practice.
We are the first eye care provider to offer the AdaptDx test in Canada! I realized I owed it to my patients to offer this innovative test to help with the early detection and management of AMD. Now, my practice gets to be the one that inspires others here in Canada to begin managing AMD earlier than ever before!
Using the AdaptDx, doctors can help patients with one of the most feared conditions and provide them hope and early treatment options.
Practices that have diversified into managing AMD are some of the most successful in the country and are well-positioned for the future.
Dark adaptation testing has allowed me to provide care earlier for many AMD patients. Science tells that I am helping these patients years before they would have developed, clinically evident disease. Patients appreciate this more proactive approach and are very accepting of it.
The primary goal of every optometrist is to preserve the vision of our patients. Detecting, monitoring and treating AMD are imperative to our mission. We can detect earlier than ever before and manage AMD by doing all we can to prevent progression to advanced stages and complications such as CNV.